Nicholas P McAndrew

Title(s)HS Assistant Clinical Professor, Medicine
SchoolMedicine
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Ribociclib plus Endocrine Therapy in Early Breast Cancer. N Engl J Med. 2024 Mar 21; 390(12):1080-1091. Slamon D, Lipatov O, Nowecki Z, McAndrew N, Kukielka-Budny B, Stroyakovskiy D, Yardley DA, Huang CS, Fasching PA, Crown J, Bardia A, Chia S, Im SA, Ruiz-Borrego M, Loi S, Xu B, Hurvitz S, Barrios C, Untch M, Moroose R, Visco F, Afenjar K, Fresco R, Severin I, Ji Y, Ghaznawi F, Li Z, Zarate JP, Chakravartty A, Taran T, Hortobagyi G. PMID: 38507751.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    2. Rectal Cancer Survival for Residual Carcinoma In Situ Vs. Pathologic Complete Response After Neoadjuvant Therapy. Dis Colon Rectum. 2024 Mar 18. Kohrman NM, Wlodarczyk JR, Ding L, McAndrew NP, Algaze SD, Cologne KG, Lee SW, Koller SE. PMID: 38498775.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. New approaches for human epidermal growth factor receptor 2-low and human epidermal growth factor receptor 2-overexpressing metastatic breast cancer. Curr Opin Obstet Gynecol. 2024 02 01; 36(1):34-39. Britten K, McAndrew N. PMID: 38170550.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Preclinical and clinical activity of DZD1516, a full blood-brain barrier-penetrant, highly selective HER2 inhibitor. Breast Cancer Res. 2023 07 06; 25(1):81. Zhang J, McAndrew NP, Wang X, Du Y, DiCarlo B, Wang M, Chen K, Yu W, Hu X. PMID: 37415239; PMCID: PMC10327353.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    5. Systemic Therapy for Early- and Late-Stage, Human Epidermal Growth Factor Receptor-2-Positive Breast Cancer. Hematol Oncol Clin North Am. 2023 02; 37(1):103-115. McAndrew NP, Hurvitz SA. PMID: 36435604.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Ruxolitinib and exemestane for estrogen receptor positive, aromatase inhibitor resistant advanced breast cancer. NPJ Breast Cancer. 2022 Nov 11; 8(1):122. Makhlin I, McAndrew NP, Wileyto EP, Clark AS, Holmes R, Bottalico LN, Mesaros C, Blair IA, Jeschke GR, Fox KR, Domchek SM, Matro JM, Bradbury AR, Feldman MD, Hexner EO, Bromberg JF, DeMichele A. PMID: 36369506; PMCID: PMC9652412.
      View in: PubMed   Mentions: 2  
    7. Chemotherapy regimen choice and patient outcomes in early-stage triple-negative breast cancer: a retrospective analysis. Ther Adv Med Oncol. 2022; 14:17588359221085556. Ghafouri SN, Nayeri RW, McAndrew NP, Hurvitz SA. PMID: 35401793; PMCID: PMC8988670.
      View in: PubMed   Mentions: 1  
    8. Updates on targeting human epidermal growth factor receptor 2-positive breast cancer: what's to know in 2021. Curr Opin Obstet Gynecol. 2022 02 01; 34(1):41-45. McAndrew NP. PMID: 34967814.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    9. Clinical Review on the Management of Hormone Receptor-Positive Metastatic Breast Cancer. JCO Oncol Pract. 2022 05; 18(5):319-327. McAndrew NP, Finn RS. PMID: 34637323.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    10. A careful reassessment of anthracycline use in curable breast cancer. NPJ Breast Cancer. 2021 Oct 08; 7(1):134. Hurvitz SA, McAndrew NP, Bardia A, Press MF, Pegram M, Crown JP, Fasching PA, Ejlertsen B, Yang EH, Glaspy JA, Slamon DJ. PMID: 34625570; PMCID: PMC8501074.
      View in: PubMed   Mentions: 15  
    11. Effects of systemic inflammation on relapse in early breast cancer. NPJ Breast Cancer. 2021 Jan 22; 7(1):7. McAndrew NP, Bottalico L, Mesaros C, Blair IA, Tsao PY, Rosado JM, Ganguly T, Song SJ, Gimotty PA, Mao JJ, DeMichele A. PMID: 33483516; PMCID: PMC7822844.
      View in: PubMed   Mentions: 11  
    12. Management of ER positive metastatic breast cancer. Semin Oncol. 2020 Oct; 47(5):270-277. McAndrew NP, Finn RS. PMID: 32958261.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    13. Early treatment-related neutropenia predicts response to palbociclib. Br J Cancer. 2020 09; 123(6):912-918. McAndrew NP, Dickson MA, Clark AS, Troxel AB, O'Hara MH, Colameco C, Gallager M, Gramlich K, Zafman K, Vaughn D, Schwartz GK, O'Dwyer PJ, DeMichele A. PMID: 32641862; PMCID: PMC7492243.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    14. Advances in Targeted Therapies for Triple-Negative Breast Cancer. Drugs. 2019 Jul; 79(11):1217-1230. McCann KE, Hurvitz SA, McAndrew N. PMID: 31254268.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    15. Combination Paclitaxel and Palbociclib: Results of a Phase I Trial in Advanced Breast Cancer. Clin Cancer Res. 2019 04 01; 25(7):2072-2079. Clark AS, McAndrew NP, Troxel A, Feldman M, Lal P, Rosen M, Burrell J, Redlinger C, Gallagher M, Bradbury AR, Domchek SM, Fox KR, O'Dwyer PJ, DeMichele AM. PMID: 30635336.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCTClinical Trials
    16. Neoadjuvant Chemotherapy Considerations in Triple-Negative Breast Cancer. J Target Ther Cancer. 2018 Feb; 7(1):52-69. McAndrew N, DeMichele A. PMID: 29577076; PMCID: PMC5865448.
      View in: PubMed   Mentions: 19  
    17. Challenges in the clinical utility of the serum test for HER2 ECD. Biochim Biophys Acta. 2012 Aug; 1826(1):199-208. Lam L, McAndrew N, Yee M, Fu T, Tchou JC, Zhang H. PMID: 22521738; PMCID: PMC3362659.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    18. Tumors at the aortoiliac/inferior vena cava bifurcation: preoperative, anesthetic, and intraoperative considerations. Am Surg. 2007 May; 73(5):440-6. Ouellette JR, Cossman DV, Sibert KS, Mcandrew NP, Silberman AW. PMID: 17520995.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    Nicholas's Networks
    Concepts (63)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (12)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCLA Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-4-g3cb31450 on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California